- Home
- PFG vs PODD Comparison
PFG vs PODD Comparison
Compare PFG & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFG
- PODD
- Stock Information
- Founded
- PFG 1879
- PODD 2000
- Country
- PFG United States
- PODD United States
- Employees
- PFG N/A
- PODD N/A
- Industry
- PFG Specialty Insurers
- PODD Medical/Dental Instruments
- Sector
- PFG Finance
- PODD Health Care
- Exchange
- PFG Nasdaq
- PODD Nasdaq
- Market Cap
- PFG 17.7B
- PODD 16.5B
- IPO Year
- PFG N/A
- PODD 2007
- Fundamental
- Price
- PFG $82.54
- PODD $276.08
- Analyst Decision
- PFG Hold
- PODD Buy
- Analyst Count
- PFG 14
- PODD 16
- Target Price
- PFG $83.64
- PODD $271.19
- AVG Volume (30 Days)
- PFG 991.8K
- PODD 533.0K
- Earning Date
- PFG 02-06-2025
- PODD 02-20-2025
- Dividend Yield
- PFG 3.54%
- PODD N/A
- EPS Growth
- PFG N/A
- PODD 235.68
- EPS
- PFG N/A
- PODD 5.74
- Revenue
- PFG $14,066,500,000.00
- PODD $1,983,900,000.00
- Revenue This Year
- PFG N/A
- PODD $23.56
- Revenue Next Year
- PFG $7.18
- PODD $18.07
- P/E Ratio
- PFG N/A
- PODD $48.28
- Revenue Growth
- PFG N/A
- PODD 27.42
- 52 Week Low
- PFG $72.21
- PODD $160.19
- 52 Week High
- PFG $91.98
- PODD $282.86
- Technical
- Relative Strength Index (RSI)
- PFG 63.23
- PODD 61.28
- Support Level
- PFG $79.70
- PODD $260.84
- Resistance Level
- PFG $79.58
- PODD $274.45
- Average True Range (ATR)
- PFG 1.33
- PODD 7.63
- MACD
- PFG 0.81
- PODD 0.86
- Stochastic Oscillator
- PFG 94.53
- PODD 75.49
About PFG Principal Financial Group Inc
Principal Financial Group Inc is a leader in Global investment management offering businesses, individuals and institutional clients a wide range of financial products and services, including retirement, asset management and insurance through diverse family of financial services companies. It operates in four business segments that are Retirement and Income Solutions, Principal Global Investors, Principal International, and United States Insurance Solutions. The company receives maximum revenue in the form of premiums.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.